TreeWAS – Variant ID: rs9537938

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N18.3 Chronic kidney disease, stage 3	0.000	0.673	0.327
N18 Chronic renal failure	0.000	0.675	0.325
N18.8 Other chronic renal failure	0.000	0.688	0.312
N18.9 Chronic renal failure, unspecified	0.000	0.700	0.300
N18.5 Chronic kidney disease, stage 5	0.000	0.710	0.290
N18.2 Chronic kidney disease, stage 2	0.000	0.711	0.289
N18.1 Chronic kidney disease, stage 1	0.000	0.748	0.252
N18.4 Chronic kidney disease, stage 4	0.000	0.799	0.200
N18.0 End-stage renal disease	0.000	0.819	0.181
N17-N19 Renal failure	0.000	0.948	0.052
J18.1 Lobar pneumonia, unspecified	0.000	0.951	0.049
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.047	0.953	0.000
J18 Pneumonia, organism unspecified	0.000	0.958	0.042
J18.9 Pneumonia, unspecified	0.000	0.959	0.041
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.039	0.961	0.000
T42.4 Benzodiazepines	0.039	0.961	0.000
Y42.5 Other oestrogens and progestogens	0.000	0.964	0.036
N17 Acute renal failure	0.000	0.966	0.034
J18.8 Other pneumonia, organism unspecified	0.000	0.966	0.034
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.030	0.970	0.000
T42.1 Iminostilbenes	0.030	0.970	0.000
T42.3 Barbiturates	0.029	0.971	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.028	0.972	0.000
T42.2 Succinimides and oxazolidinediones	0.028	0.972	0.000
J18.2 Hypostatic pneumonia, unspecified	0.000	0.972	0.028
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.027	0.972	0.000
N17.1 Acute renal failure with acute cortical necrosis	0.000	0.974	0.026
N17.2 Acute renal failure with medullary necrosis	0.000	0.975	0.025
T42.0 Hydantoin derivatives	0.024	0.976	0.000
N17.8 Other acute renal failure	0.000	0.976	0.023
N17.0 Acute renal failure with tubular necrosis	0.000	0.977	0.023
N17.9 Acute renal failure, unspecified	0.000	0.977	0.023
J18.0 Bronchopneumonia, unspecified	0.000	0.978	0.022
J09-J18 Influenza and pneumonia	0.000	0.979	0.021
J15 Bacterial pneumonia, not elsewhere classified	0.000	0.980	0.020
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.000	0.982	0.018
J15.1 Pneumonia due to Pseudomonas	0.000	0.983	0.017
J13 Pneumonia due to Streptococcus pneumoniae	0.000	0.983	0.017
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.000	0.984	0.016
J15.8 Other bacterial pneumonia	0.000	0.984	0.016
J15.9 Bacterial pneumonia, unspecified	0.000	0.984	0.016
J12 Viral pneumonia, not elsewhere classified	0.000	0.985	0.015
U80.0 Penicillin resistant agent	0.000	0.985	0.015
J15.6 Pneumonia due to other aerobic Gram-negative bacteria	0.000	0.985	0.015
J10 Influenza due to identified influenza virus	0.000	0.985	0.015
J15.2 Pneumonia due to staphylococcus	0.000	0.985	0.015
J15.3 Pneumonia due to streptococcus, group B	0.000	0.986	0.014
J09 Influenza due to certain identified influenza virus	0.000	0.986	0.014
J15.0 Pneumonia due to Klebsiella pneumoniae	0.000	0.986	0.013
J16.8 Pneumonia due to other specified infectious organisms	0.000	0.987	0.013
J15.5 Pneumonia due to Escherichia coli	0.000	0.987	0.013
H34.8 Other retinal vascular occlusions	0.000	0.987	0.013
J12.9 Viral pneumonia, unspecified	0.000	0.987	0.012
U80.1 Methicillin resistant agent	0.000	0.988	0.012
J16.0 Chlamydial pneumonia	0.000	0.988	0.012
J12.2 Parainfluenza virus pneumonia	0.000	0.988	0.012
U80 Agent resistant to penicillin and related antibiotics	0.000	0.988	0.012
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.000	0.988	0.012
L40.5 Arthropathic psoriasis	0.000	0.988	0.012
J17 Pneumonia in diseases classified elsewhere	0.000	0.988	0.012
J11 Influenza, virus not identified	0.000	0.988	0.012
J15.4 Pneumonia due to other streptococci	0.000	0.989	0.011
J12.8 Other viral pneumonia	0.000	0.989	0.011
J12.3 Human metapneumovirus pneumonia	0.000	0.989	0.011
J12.0 Adenoviral pneumonia	0.000	0.989	0.011
J14 Pneumonia due to Haemophilus influenzae	0.000	0.989	0.011
H34 Retinal vascular occlusions	0.000	0.989	0.011
C32.0 Glottis	0.000	0.989	0.011
J10.8 Influenza with other manifestations, influenza virus identified	0.000	0.989	0.011
Y42.0 Glucocorticoids and synthetic analogs	0.000	0.989	0.011
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.989	0.011
H34.2 Other retinal artery occlusions	0.000	0.990	0.010
H34.1 Central retinal artery occlusion	0.000	0.990	0.010
J10.0 Influenza with pneumonia, influenza virus identified	0.000	0.991	0.009
C32 Malignant neoplasm of larynx	0.000	0.991	0.009
J12.1 Respiratory syncytial virus pneumonia	0.000	0.991	0.009
C32.9 Larynx, unspecified	0.000	0.991	0.009
H34.9 Retinal vascular occlusion, unspecified	0.000	0.991	0.009
J17.2 Pneumonia in mycoses	0.000	0.991	0.009
J11.8 Influenza with other manifestations, virus not identified	0.000	0.991	0.009
J17.8 Pneumonia in other diseases classified elsewhere	0.000	0.991	0.008
J17.0 Pneumonia in bacterial diseases classified elsewhere	0.000	0.991	0.009
C32.1 Supraglottis	0.000	0.992	0.008
H34.0 Transient retinal artery occlusion	0.000	0.992	0.008
Z51.0 Radiotherapy session	0.000	0.992	0.008
Y42.1 Thyroid hormones and substitutes	0.000	0.992	0.008
J11.0 Influenza with pneumonia, virus not identified	0.000	0.992	0.008
J17.3 Pneumonia in parasitic diseases	0.000	0.992	0.008
N62 Hypertrophy of breast	0.000	0.992	0.008
Y42.9 Other and unspecified hormone antagonists	0.000	0.992	0.008
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.000	0.992	0.008
Y42.4 Oral contraceptives	0.000	0.993	0.007
Y42.2 Antithyroid drugs	0.000	0.993	0.007
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.993	0.007
L40 Psoriasis	0.000	0.993	0.007
C32.8 Overlapping lesion of larynx	0.000	0.993	0.007
C32.2 Subglottis	0.000	0.993	0.007
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.993	0.007
L40.1 Generalised pustular psoriasis	0.000	0.993	0.007
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.993	0.006
C32.3 Laryngeal cartilage	0.000	0.994	0.006
N99.3 Prolapse of vaginal vault after hysterectomy	0.006	0.994	0.000
J43.9 Emphysema, unspecified	0.000	0.994	0.006
J17.1 Pneumonia in viral diseases classified elsewhere	0.000	0.994	0.006
J11.1 Influenza with other respiratory manifestations, virus not identified	0.000	0.994	0.006
L40.0 Psoriasis vulgaris	0.000	0.994	0.006
N19 Unspecified renal failure	0.000	0.994	0.006
L40.8 Other psoriasis	0.000	0.994	0.005
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
L40.2 Acrodermatitis continua	0.000	0.995	0.005
R26.8 Other and unspecified abnormalities of gait and mobility	0.000	0.995	0.005
J39.2 Other diseases of pharynx	0.000	0.995	0.005
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
L40.4 Guttate psoriasis	0.000	0.995	0.005
T40.4 Other synthetic narcotics	0.005	0.995	0.000
L40.3 Pustulosis palmaris et plantaris	0.000	0.995	0.005
H52.1 Myopia	0.005	0.995	0.000
I95.1 Orthostatic hypotension	0.000	0.995	0.005
H02.8 Other specified disorders of eyelid	0.000	0.995	0.005
H02.6 Xanthelasma of eyelid	0.000	0.995	0.005
H02.1 Ectropion of eyelid	0.000	0.995	0.005
Y83.3 Surgical operation with formation of external stoma	0.000	0.995	0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.995	0.000
Z99.1 Dependence on respirator	0.005	0.995	0.000
T45.5 Anticoagulants	0.004	0.995	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.996	0.004
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.996	0.000
T48.5 Anti-common-cold drugs	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.000	0.996	0.004
T85.9 Unspecified complication of internal prosthetic device, implant and graft	0.000	0.996	0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y42.7 Androgens and anabolic congeners	0.000	0.996	0.004
H02 Other disorders of eyelid	0.000	0.996	0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
J43 Emphysema	0.000	0.996	0.004
R26.2 Difficulty in walking, not elsewhere classified	0.000	0.996	0.004
R26 Abnormalities of gait and mobility	0.000	0.996	0.004
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.996	0.000
T48.4 Expectorants	0.003	0.996	0.000
T48.3 Antitussives	0.003	0.996	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.996	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.996	0.000
T48.0 Oxytocic drugs	0.003	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.996	0.000
A04.7 Enterocolitis due to Clostridium difficile	0.000	0.996	0.004
Y44.2 Anticoagulants	0.000	0.996	0.004
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.996	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.996	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.996	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.996	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.996	0.000
T44.0 Anticholinesterase agents	0.003	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.996	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.996	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
C33 Malignant neoplasm of trachea	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
J43.8 Other emphysema	0.000	0.997	0.003
T40.5 Cocaine	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
R26.3 Immobility	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
C37 Malignant neoplasm of thymus	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.000	0.997	0.003
H02.7 Other degenerative disorders of eyelid and periocular area	0.000	0.997	0.003
H02.2 Lagophthalmos	0.000	0.997	0.003
L40.9 Psoriasis, unspecified	0.000	0.997	0.003
T36.0 Penicillins	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.000	0.997	0.003
H81.0 Meniere's disease	0.000	0.997	0.003
U50 Level of care administered to neonates	0.000	0.997	0.003
U07 Emergency use of U07	0.000	0.997	0.003
U06 Emergency use of U06	0.000	0.997	0.003
U04 Severe acute respiratory syndrome [SARS]	0.000	0.997	0.003
U52 First in a series of a regular day/night admissions	0.000	0.997	0.003
C71.9 Brain, unspecified	0.000	0.997	0.003
T40.6 Other and unspecified narcotics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
C31 Malignant neoplasm of accessory sinuses	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
I50.1 Left ventricular failure	0.000	0.997	0.003
J43.1 Panlobular emphysema	0.000	0.997	0.003
J43.0 MacLeod's syndrome	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
J43.2 Centrilobular emphysema	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
R26.1 Paralytic gait	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
H02.0 Entropion and trichiasis of eyelid	0.000	0.997	0.003
H02.3 Blepharochalasis	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Q87.8 Other specified congenital malformation syndromes, not elsewhere classified	0.000	0.997	0.003
C34 Malignant neoplasm of bronchus and lung	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
C34.8 Overlapping lesion of bronchus and lung	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
T37.5 Antiviral drugs	0.002	0.997	0.000
T37.4 Anthelminthics	0.002	0.997	0.000
T37.3 Other antiprotozoal drugs	0.002	0.997	0.000
T37.1 Antimycobacterial drugs	0.002	0.997	0.000
T37.0 Sulphonamides	0.002	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.997	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.997	0.003
C71 Malignant neoplasm of brain	0.000	0.997	0.003
L71.1 Rhinophyma	0.000	0.997	0.003
C71.8 Overlapping lesion of brain	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.997	0.000
T46.7 Peripheral vasodilators	0.002	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
L40-L45 Papulosquamous disorders	0.000	0.997	0.003
I22.8 Subsequent myocardial infarction of other sites	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.997	0.000
C39.9 Ill-defined sites within the respiratory system	0.000	0.997	0.002
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.000	0.997	0.002
C39.0 Upper respiratory tract, part unspecified	0.000	0.997	0.002
C71.2 Temporal lobe	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.997	0.000
C30.1 Middle ear	0.000	0.998	0.002
R76.8 Other specified abnormal immunological findings in serum	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.998	0.002
U06.9 Emergency use of U06.9	0.000	0.998	0.002
U06.8 Emergency use of U06.8	0.000	0.998	0.002
U06.7 Emergency use of U06.7	0.000	0.998	0.002
U06.6 Emergency use of U06.6	0.000	0.998	0.002
U06.5 Emergency use of U06.5	0.000	0.998	0.002
U06.4 Emergency use of U06.4	0.000	0.998	0.002
U06.3 Emergency use of U06.3	0.000	0.998	0.002
U06.2 Emergency use of U06.2	0.000	0.998	0.002
U06.1 Emergency use of U06.1	0.000	0.998	0.002
U06.0 Emergency use of U06.0	0.000	0.998	0.002
U07.9 Emergency use of U07.9	0.000	0.998	0.002
U07.8 Emergency use of U07.8	0.000	0.998	0.002
U07.7 Emergency use of U07.7	0.000	0.998	0.002
U07.6 Emergency use of U07.6	0.000	0.998	0.002
U07.5 Emergency use of U07.5	0.000	0.998	0.002
U07.4 Emergency use of U07.4	0.000	0.998	0.002
U07.3 Emergency use of U07.3	0.000	0.998	0.002
U07.2 Emergency use of U07.2	0.000	0.998	0.002
U07.1 Emergency use of U07.1	0.000	0.998	0.002
U07.0 Emergency use of U07.0	0.000	0.998	0.002
U50.9 Inquest Adjourned Death	0.000	0.998	0.002
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.998	0.002
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.998	0.002
U50.1 Level of care administered to neonates (Special Care)	0.000	0.998	0.002
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.998	0.002
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.998	0.002
C31.9 Accessory sinus, unspecified	0.000	0.998	0.002
C31.8 Overlapping lesion of accessory sinuses	0.000	0.998	0.002
C31.3 Sphenoidal sinus	0.000	0.998	0.002
C31.2 Frontal sinus	0.000	0.998	0.002
C31.1 Ethmoidal sinus	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
C71.4 Occipital lobe	0.000	0.998	0.002
C34.2 Middle lobe, bronchus or lung	0.000	0.998	0.002
C38.4 Pleura	0.000	0.998	0.002
J39 Other diseases of upper respiratory tract	0.000	0.998	0.002
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.000	0.998	0.002
C38.2 Posterior mediastinum	0.000	0.998	0.002
C38.1 Anterior mediastinum	0.000	0.998	0.002
C38.0 Heart	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
C30.0 Nasal cavity	0.000	0.998	0.002
Y85.9 Sequelae of other and unspecified transport accidents	0.002	0.998	0.000
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.998	0.002
C31.0 Maxillary sinus	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
U51 Admission status on psychiatric patients	0.000	0.998	0.002
C71.0 Cerebrum, except lobes and ventricles	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
L44 Other papulosquamous disorders	0.000	0.998	0.002
C34.9 Bronchus or lung, unspecified	0.000	0.998	0.002
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.998	0.002
C34.3 Lower lobe, bronchus or lung	0.000	0.998	0.002
C71.1 Frontal lobe	0.000	0.998	0.002
M07.3 Other psoriatic arthropathies	0.000	0.998	0.002
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.998	0.002
C71.7 Brain stem	0.000	0.998	0.002
C71.6 Cerebellum	0.000	0.998	0.002
C71.5 Cerebral ventricle	0.000	0.998	0.002
K14.8 Other diseases of tongue	0.000	0.998	0.002
K60.5 Anorectal fistula	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
C38.3 Mediastinum, part unspecified	0.000	0.998	0.002
D37.4 Colon	0.002	0.998	0.000
H16.0 Corneal ulcer	0.000	0.998	0.002
S99.9 Unspecified injury of ankle and foot	0.000	0.998	0.002
I74 Arterial embolism and thrombosis	0.000	0.998	0.002
L42 Pityriasis rosea	0.000	0.998	0.002
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.000	0.998	0.002
L45 Papulosquamous disorders in diseases classified elsewhere	0.000	0.998	0.002
H81.9 Disorder of vestibular function, unspecified	0.000	0.998	0.002
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.998	0.002
J39.1 Other abscess of pharynx	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.998	0.000
H81 Disorders of vestibular function	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
L41 Parapsoriasis	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
L44.0 Pityriasis rubra pilaris	0.000	0.998	0.002
I22 Subsequent myocardial infarction	0.000	0.998	0.002
M07.38 Other psoriatic arthropathies (Other)	0.000	0.998	0.002
H02.5 Other disorders affecting eyelid function	0.000	0.998	0.002
O34.7 Maternal care for abnormality of vulva and perineum	0.002	0.998	0.000
Q18.1 Preauricular sinus and cyst	0.002	0.998	0.000
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.000	0.998	0.002
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.000	0.998	0.002
H81.3 Other peripheral vertigo	0.000	0.998	0.002
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.000	0.998	0.002
J39.9 Disease of upper respiratory tract, unspecified	0.000	0.998	0.002
F52.2 Failure of genital response	0.002	0.998	0.000
R45.6 Physical violence	0.000	0.998	0.002
S00.3 Superficial injury of nose	0.000	0.998	0.002
U81.8 Agent resistant to other vancomycin-related antibiotic	0.001	0.998	0.001
H81.1 Benign paroxysmal vertigo	0.000	0.998	0.002
R45.2 Unhappiness	0.000	0.998	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
S62.50 Fracture of thumb (closed)	0.000	0.998	0.002
S82.00 Fracture of patella (closed)	0.002	0.998	0.000
R26.0 Ataxic gait	0.000	0.998	0.002
R45 Symptoms and signs involving emotional state	0.000	0.998	0.002
C34.0 Main bronchus	0.000	0.998	0.002
L44.9 Papulosquamous disorder, unspecified	0.000	0.998	0.002
L44.8 Other specified papulosquamous disorders	0.000	0.998	0.002
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.000	0.998	0.002
L44.3 Lichen ruber moniliformis	0.000	0.998	0.002
L44.2 Lichen striatus	0.000	0.998	0.002
L44.1 Lichen nitidus	0.000	0.998	0.002
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.000	0.998	0.002
Y44 Agents primarily affecting blood constituents	0.000	0.998	0.002
M07.34 Other psoriatic arthropathies (Hand)	0.000	0.998	0.002
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.998	0.002
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.998	0.002
C71.3 Parietal lobe	0.000	0.998	0.002
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.000	0.998	0.002
J39.8 Other specified diseases of upper respiratory tract	0.000	0.998	0.002
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.998	0.002
R45.7 State of emotional shock and stress, unspecified	0.000	0.998	0.002
J90 Pleural effusion, not elsewhere classified	0.000	0.998	0.002
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.998	0.002
J39.0 Retropharyngeal and parapharyngeal abscess	0.000	0.998	0.002
C50.8 Overlapping lesion of breast	0.000	0.998	0.002
K60.2 Anal fissure, unspecified	0.000	0.998	0.002
R74.8 Abnormal levels of other serum enzymes	0.000	0.998	0.002
Y44.6 Natural blood and blood products	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
L41.9 Parapsoriasis, unspecified	0.000	0.998	0.002
L41.8 Other parapsoriasis	0.000	0.998	0.002
L41.5 Retiform parapsoriasis	0.000	0.998	0.002
L41.4 Large plaque parapsoriasis	0.000	0.998	0.002
L41.3 Small plaque parapsoriasis	0.000	0.998	0.002
L41.2 Lymphomatoid papulosis	0.000	0.998	0.002
L41.0 Pityriasis lichenoides et varioliformis acuta	0.000	0.998	0.002
R45.1 Restlessness and agitation	0.000	0.998	0.002
R45.8 Other symptoms and signs involving emotional state	0.000	0.998	0.002
H02.9 Disorder of eyelid, unspecified	0.000	0.998	0.002
I74.8 Embolism and thrombosis of other arteries	0.000	0.998	0.002
R45.5 Hostility	0.000	0.998	0.002
C56 Malignant neoplasm of ovary	0.000	0.998	0.002
L41.1 Pityriasis lichenoides chronica	0.000	0.998	0.001
R45.4 Irritability and anger	0.000	0.998	0.002
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.998	0.002
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.000	0.998	0.002
S62.51 Fracture of thumb (open)	0.000	0.998	0.002
H81.2 Vestibular neuronitis	0.000	0.998	0.002
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.998	0.002
H53.8 Other visual disturbances	0.000	0.998	0.002
S99.8 Other specified injuries of ankle and foot	0.000	0.998	0.002
U81.0 Vancomycin resistant agent	0.001	0.998	0.001
Q87.0 Congenital malformation syndromes predominantly affecting facial appearance	0.000	0.998	0.002
Z63.4 Disappearance and death of family member	0.000	0.998	0.002
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.998	0.001
I74.0 Embolism and thrombosis of abdominal aorta	0.000	0.998	0.001
Q87.2 Congenital malformation syndromes predominantly involving limbs	0.000	0.998	0.002
R45.3 Demoralisation and apathy	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.998	0.001
Y44.7 Plasma substitutes	0.000	0.998	0.001
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.998	0.001
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.001	0.998	0.000
D47.2 Monoclonal gammopathy	0.002	0.998	0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.002	0.998	0.000
H81.8 Other disorders of vestibular function	0.000	0.998	0.001
Chapter XXII Codes for special purposes	0.000	0.998	0.002
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.998	0.000
I74.9 Embolism and thrombosis of unspecified artery	0.000	0.998	0.001
Z95.8 Presence of other cardiac and vascular implants and grafts	0.000	0.998	0.002
H90.5 Sensorineural hearing loss, unspecified	0.000	0.998	0.002
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.998	0.001
H81.4 Vertigo of central origin	0.000	0.998	0.001
Q87.1 Congenital malformation syndromes predominantly associated with short stature	0.000	0.998	0.001
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.998	0.001
G12.2 Motor neuron disease	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.001	0.998	0.000
T39.2 Pyrazolone derivatives	0.001	0.998	0.000
Y44.5 Thrombolytic drugs	0.000	0.998	0.001
S99 Other and unspecified injuries of ankle and foot	0.000	0.998	0.002
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.998	0.002
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.001
Y45.1 Salicylates	0.002	0.998	0.000
E21.0 Primary hyperparathyroidism	0.002	0.998	0.000
E04.2 Non-toxic multinodular goitre	0.002	0.998	0.000
H02.4 Ptosis of eyelid	0.000	0.998	0.002
Q87.5 Other congenital malformation syndromes with other skeletal changes	0.000	0.998	0.001
Q87.3 Congenital malformation syndromes involving early overgrowth	0.000	0.998	0.001
O44.0 Placenta praevia specified as without haemorrhage	0.001	0.998	0.000
S00.8 Superficial injury of other parts of head	0.000	0.998	0.002
L43 Lichen planus	0.000	0.998	0.001
I22.0 Subsequent myocardial infarction of anterior wall	0.000	0.999	0.001
Q14.1 Congenital malformation of retina	0.001	0.999	0.000
S62.5 Fracture of thumb	0.000	0.999	0.001
T50.9 Other and unspecified drugs, medicaments and biological substances	0.001	0.999	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.999	0.001
D47.3 Essential (haemorrhagic) thrombocythaemia	0.001	0.999	0.000
G58.8 Other specified mononeuropathies	0.000	0.999	0.001
D47.4 Osteomyelofibrosis	0.001	0.999	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.999	0.001
K07.3 Anomalies of tooth position	0.000	0.999	0.001
R45.0 Nervousness	0.000	0.999	0.001
H16 Keratitis	0.000	0.999	0.001
S99.7 Multiple injuries of ankle and foot	0.000	0.999	0.001
K07.9 Dentofacial anomaly, unspecified	0.000	0.999	0.001
Q12.0 Congenital cataract	0.001	0.999	0.000
Q38.7 Pharyngeal pouch	0.000	0.999	0.001
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations